Skip to content

DockTales for Chronic Pain

Evaluating Feasibility and Acceptability of DockTales for Chronic Pain

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07680894
Enrollment
60
Registered
2026-07-02
Start date
2027-07-17
Completion date
2029-10-24
Last updated
2026-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Chronic Pain Syndrome

Brief summary

This study will evaluate the feasibility and acceptability of DockTales, a mobile health tool designed for adults with chronic pain. DockTales supports pain and sleep tracking through brief diaries, body-map pain reporting, reflective journaling, visual summaries, and optional AI-supported interaction. The study will be conducted completely remotely. Participants will complete 2 weeks of DockTales use and 2 weeks of REDCap-based daily monitoring, with the order randomized. The main goal is to determine whether DockTales is usable, acceptable, engaging, and practical for adults with chronic pain compared with standard REDCap monitoring.

Detailed description

This is a fully remote, randomized crossover pilot clinical trial designed to evaluate the feasibility and acceptability of DockTales among adults with chronic pain. Chronic pain is defined as pain lasting for more than 3 months. A total of up to 60 participants will be enrolled. Participants will be randomized in a 1:1 ratio to one of two study sequences. Participants assigned to Sequence 1 will complete 2 weeks of DockTales use followed by 2 weeks of REDCap-based daily monitoring. Participants assigned to Sequence 2 will complete 2 weeks of REDCap-based daily monitoring followed by 2 weeks of DockTales use. All participants will complete both study conditions. Participants will complete questionnaires at baseline, after the first 2-week period, and after the second 2-week period. These assessments will evaluate feasibility, acceptability, usability, burden, engagement, technical issues, participant preference, and exploratory pain and sleep-related outcomes. Some participants may also complete an optional remote semi-structured interview after finishing both study conditions. The primary outcomes are feasibility and acceptability. Feasibility will be assessed through recruitment, retention, adherence, completion of DockTales use, completion of REDCap monitoring, missing data, and technical issues. Acceptability will be assessed through satisfaction, engagement, perceived usefulness, ease of use, burden, willingness to use DockTales again, and preference between DockTales and REDCap monitoring.

Interventions

BEHAVIORALDockTales

DockTales includes several core features: 1. Brief diary entries 2. Body-map pain reporting/feedback 3. Reflective journaling 4. Optional AI-supported interaction The AI-supported feature is not intended to provide medical advice, diagnosis, treatment recommendations, mental health care, or emergency support. The focus of the DockTales intervention is to support self-monitoring, reflection, engagement, and user experience among adults with chronic pain.

OTHERREDCap monitoring

REDCap will be used to monitor daily symptoms and diaries from people with chronic pain.

Sponsors

University of Maryland, Baltimore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Both the experimenter and participants know the interventions (DockTales and REDCap). The outcome assessor will be blinded about the study conditions.

Intervention model description

All participants will complete 2 weeks of DockTales use and 2 weeks of REDCap standard monitoring.

Eligibility

Sex/Gender
ALL
Age
18 Years to 88 Years
Healthy volunteers
No

Inclusion criteria

* Age ( 18-88 years old) * English speaker (written and spoken) * Chronic pain for at least 3 months * Smartphone/text messaging capability

Exclusion criteria

* Any personal history of mania, schizophrenia, or other psychoses * Severe psychiatric condition (e.g. schizophrenia, bipolar disorders, autism) leading to hospitalization within the last 3 years. * Pregnancy or breast feeding * Impaired or uncorrected hearing

Design outcomes

Primary

MeasureTime frameDescription
Enrollment rateAt the enrollmentEnrollment rate: the proportion (%) of recruited participants who enrolled in the study.
Retention rateEnd of Week 4Retention rate: the proportion (%) of enrolled participants who finished the study
Module completion rateEnd of Week 4Module rate: the proportion (%) of completed modules in the DockTales app. The DockTales app contains 1) daily monitoring module; 2) navigation map module; 3) AI avatar companion module; and 4) daily dairy module.
Daily survey completion rateEnd of Week 4Module rate: the proportion (%) of completed daily surveys sent through DockTales and REDCap-based surveys.
Levels of satisfactionEnd of Week 2 and Week 4Levels of satisfaction are assessed using a visual analogue scale ranging from 0 = not satisfied at all to 100 = extremely satisfied.
Levels of enjoymentEnd of Week 2 and Week 4Levels of enjoyment are assessed using a visual analogue scale ranging from 0 = not enjoyed at all to 100 = extremely enjoyed.
Levels of engagementEnd of Week 2 and Week 4Levels of engagement are assessed using a visual analogue scale ranging from 0 = not engaged at all to 100 = extremely engaged.

Countries

United States

Contacts

CONTACTYang Wang, PhD
yang.wang@umaryland.edu410-706-7824

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 4, 2026